Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

LORATADINE TABLETS

Awarded
SPE2DP26F7480Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Logistics Agency awarded a firm-fixed-price delivery order, SPE2DP26F7480, to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of 96 units of loratadine tablets under the National Stock Number 6505013770448. The total contract value is $1,920.96, with a unit price of $20.01 per unit, and the order was issued on July 14, 2026, under the basic contract SPE2DX25D9900. Delivery is required FOB destination to 6090 Strathmore Road, Richmond, VA 23237-0000, no later than July 29, 2026, with all packaging and documentation clearly marked with the contract and delivery order numbers and a traceable shipping identifier. The product is procured as a commercial off-the-shelf pharmaceutical item, with acceptance to occur at the destination upon inspection by the Government, and no specific quality standards beyond contractual conformity are cited. The awardee is certified as a small business, small disadvantaged business, and women-owned small business, triggering ongoing compliance and reporting obligations under FAR and SBA programs. Payment will be processed through DLA Troop Support’s Medical Supply Chain Pharmacy FSA in Philadelphia, Pennsylvania, using a voucher-based system, with the remittance address listed as Columbus, Ohio. No contract clauses, special requirements, or detailed inspection specifications are explicitly included in the order, and all terms are incorporated by reference from the base contract; no Contracting Officer’s Representative is named, and the contracting officer is Lisa Quinn, DLA. Packaging must avoid parcel post and use traceable shipping methods, with no MIL-STDs or barcoding standards referenced in the documentation.

General Info

DMS PHARMACEUTICAL GROUP INC awarded $1,920.96 for LORATADINE TABLETS under DLA contract SPE2DX25D9900.

Contract Value

$1,920.96

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

IL, USA

Set-Aside

NONE

Award Issued Date

Documents

2
PDF
PDF

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F7480 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $1,920.96 Award Date: 07-14-2026 Delivery order under: SPE2DX25D9900 Line items: - LORATADINE TABLETS (NSN/Part 6505013770448, PR 7017496414)

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS